Cholangiocarcinoma, unresectable locally advanced or metastatic: Treatment of previously treated, unresectable locally advanced or metastatic cholangiocarcinoma in adults with a fibroblast growth factor receptor 2 (FGFR2) fusion or other rearrangement as detected by an approved test.